Atrial natriureticpeptide-26 (human reduced) (9CI)(100691-58-5)
- Name: Atrial natriureticpeptide-26 (human reduced) (9CI)
- Synonyms:Atriopeptin-21(rat reduced),N-(N2-L-arginyl-L-arginyl)-8-L-methionine-21a-L-phenylalanine-21b-L-arginine-21c-L-tyrosine-;297: PN: WO0069900 SEQID: 479 unclaimed sequence; 396: PN: US20090175821 SEQID:479 claimed protein; L 364370; L-Tyrosine, L-arginyl-L-arginyl-L-seryl-L-seryl-L-cysteinyl-L-phenylalanylglycylglycyl-L-arginyl-L-methionyl-L-a-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-glutaminyl-L-serylglycyl-L-leucylglycyl-L-cysteinyl-L-asparaginyl-L-seryl-L-phenylalanyl-L-arginyl-
- Molecular Formula:C118H189 N43 O36 S3
- Molecular Weight:
- CAS Registry Number:100691-58-5
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 58971-11-2/3-Bromophenethylamine
- 85700-43-2/Clavulone II
- 72586-21-1/alcindoromycin
- 88798-74-7/eckol
- 3760-96-1/1-(Dimethylamino)-2-butanol
- 6361-41-7/2-Acetamido-8-naphthol-6-sufonic acid (N-acetyl gamma acid)
- 68891-14-5/Oxirane, methyl-, polymer with oxirane, ether with beta-D-fructofuranosyl alpha-D-glucopyranoside, reaction products with 1,3-bis(3-isocyanatomethylphenyl)-1,3-diazetidine-2,4-dione and 1,3,5-tris(3-isocyanatomethylphenyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione
- 102714-08-9/klebocin
- 74499-60-8/1-(1,2,3,4-tetrahydro-4,4-dimethyl-1-naphthyl)propan-1-one
- 6947-74-6/1-(naphthalen-1-ylmethyl)piperidine
- 58046-12-1/dimethyl phenylphosphoramidate
- 102488-56-2/Dispegatrine
- 7498-39-7/5-(hydrazinylmethyl)-2-methylpyrimidin-4(3H)-one
- 72230-98-9/2-Propenoic acid, 2-methyl-, hydroxymethyl ester, polymer with butyl 2-propenoate, methyl 2-methyl-2-propenoate and 2-propenoic acid
- 84988-84-1/Fatty acids, tall-oil, branched nonyl esters
- 152423-13-7/1-methyl-6-phenylpyrazolo[3,4-d][1,3]thiazolo[3,2-a]pyrimidin-4(1H)-one
- 62218-53-5/(4R)-2,6,6-Trimethyl-4β-(β-D-glucopyranosyloxy)-1-cyclohexene-1-carboxylic acid
- 68187-83-7/Acid chlorides, linseed-oil
- 28675-08-3/Phenyl ether diehloro
- 100691-58-5/Atrial natriureticpeptide-26 (human reduced) (9CI)
- 25005-95-2/2,3-BIS-(2'-PYRIDYL)-5,6-DIHYDROPYRAZINE
- 5324-03-8/butyl 4-[(1-butoxy-1-oxopropan-2-yl)oxy]-2,6-dimethyl-7-oxo-3,5,8-trioxa-4-phosphadodecan-1-oate 4-oxide
- 6070-14-0/menthyl butyrate
- 99892-20-3/1,4,7-tris[(4-methylphenyl)sulfonyl]-10-(methylsulfonyl)-1,4,7,10-tetraazacyclododecane
- 154546-88-0/Phenol,2,5-bis[5-(1,1-dimethylethyl)-2-benzoxazolyl]-
- 170938-55-3/1-[(4-fluorophenyl)(4-phenyl-1H-pyrrol-3-yl)methyl]-1H-imidazole
- 74038-13-4/1,1-dimethyl-4-(1-thiophen-2-ylcyclohexyl)piperazin-1-ium iodide
- 114558-81-5/Spiro[4H-cyclopenta[c]pyridine-4,9'-[1,4]ethano[4H]cyclopenta[c]pyridine]-4'-carboxaldehyde,1',4a,4'a,5,5',6,6',7,7',7'a-decahydro-8'-hydroxy-7,7'-dimethyl- (9CI)
- 770-18-3/BenzeneMethanaMine, 3-fluoro-N,N-diMethyl-
- 93272-49-2/2-[3-(oxiran-2-yl)propyl]-1H-isoindole-1,3(2H)-dione